“…More advanced models that also include components of the tumor stroma have been developed for evaluating drug and immune cell responses, although with limited screening capabilities ( Ayuso et al., 2021 ; Cui et al., 2020 ; Nashimoto et al., 2020 ). Despite recent developments of sophisticated cell culture tools combined with live cell imaging readout ( Ayuso et al., 2019 , 2021 ; Berg et al., 2019 ; Gopal et al., 2021 ; Lemon and McDole, 2020 ; Lin et al., 2020 ; Olofsson et al., 2018 ; Park et al., 2019 ; Shelton et al., 2021 ; Wen et al., 2020 ; Zhou et al., 2020 ), it is still rare with assays that manage to combine high-content screening over long periods of time with sufficient imaging quality to examine cellular behavior with single-cell resolution.…”